Research indicates that the expression levels of general stem cell markers (such as CD34 and CD73), genes linked to cancer stem cells (CD99 and ITGB3), and an embryonic stem cell marker (GGT1) are elevated within this subset [27, 28]. This evidence concerns the gene CD99 and cancer.